Clinical trials
Phase 3 Rhinitis, Allergic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
102 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 6 |
| 2005 | 6 |
| 2006 | 6 |
| 2007 | 2 |
| 2008 | 8 |
| 2009 | 5 |
| 2010 | 6 |
| 2011 | 1 |
| 2012 | 7 |
| 2013 | 6 |
| 2014 | 5 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 7 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 77 |
| Unknown status | 10 |
| Withdrawn | 6 |
| Recruiting | 5 |
| Terminated | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Organon and Co | 14 |
| GlaxoSmithKline | 9 |
| ALK-Abelló A/S | 8 |
| EMS | 7 |
| AstraZeneca | 5 |
| Roxall Medizin | 5 |
| Inmunotek S.L. | 4 |
| Chang Gung Memorial Hospital | 3 |
| Eurofarma Laboratorios S.A. | 3 |
| Medical University of Lublin | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rhinitis, Allergic | 102 |
| Rhinitis, Allergic, Seasonal | 25 |
| Rhinitis, Allergic, Perennial | 18 |
| Hypersensitivity | 14 |
| Asthma | 9 |
| Rhinitis | 7 |
| Conjunctivitis, Allergic | 4 |
| Chronic Urticaria | 2 |
| Nasal Obstruction | 2 |
| Bronchiolitis | 1 |
Trials
Showing 51 to 75 of 102. Each trial links to its page on Pharma Observatory.
2 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.